Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens

Morality Clinical Trial

— FESF-Amiens  

Official title:

Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03117868
• Other study ID #: RNI2016-04
• Status: Completed
• Start date: June 2, 2016
• Est. completion date: November 28, 2017

Study information

• Verified date: July 2020
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Fractures of the upper femur (EFSF) represent a major public health problem in the elderly. Approximately 1.6 million patients are victims each year of an EFSF and this number is increasing as a result of the aging of the population.

In a recent Amiens retrospective study the mortality was estimated to be 22.5% at 1 year of the fracture. In surviving patients, the impact on loss of autonomy and degradation of quality of life is considerable.

The reduction of the incidence of post-operative complications includes the identification of risk factors.

No prospective study in Amiens has investigated the mortality and the study of the variables involved in the prognosis and long-term mortality of these patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 310
• Est. completion date: November 28, 2017
• Est. primary completion date: November 28, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All the patients operated from a fracture of traumatic origin of the ESF to the emergency block at the CHU of Amiens

• Patients transferred to the CHU after being cared for in another structure will be included.

• If a patient successively presents a fracture of each upper extremity of the femur outside of a surgical resumption, two inclusions will be realized

Exclusion Criteria:

• Do not include non-traumatic fractures of the upper end of the femur (pathological fractures: cancer, for example)

• Fractures of the upper end of the femur associated with polytrauma will not be included.

Related Conditions & MeSH terms

• Femoral Fractures
• Femur Fracture
• Fractures, Bone
• Morality

Intervention

Other:
• Study of mortality at 6 months
The objective is to provide strong arguments for establishing a dynamic of collective care for patients suffering from an EFSF

Locations

Country	Name	City	State
France	CHU Amiens Picardie	Amiens	Picardie

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality at 6 months of EFSF patients		6 months